Rachael Leigh Cook is sharing more about the iconic 1990s “This Is Your Brain on Drugs” advertisement that skyrocketed her ...

Bristol Myers BMY recently secured a meaningful label expansion for Sotyktu, with the FDA approving the drug for adults with ...

Analysts note that treatment durability is a key unmet need in HS, and will define a drug’s commercial success on the market.

Senior Department of Homeland Security officials have challenged the White House to launch a “full audit” of the vast ...

Alumis Inc. upgraded to Buy on strong Phase 3 psoriasis data for envudeucitinib, NDA plans, and upside valuation. Click here ...

Clarity Pharmaceuticals (ASX: CU6) ('Clarity' or 'Company'), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...

(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...

This partnership follows a clear strategic pattern. In February 2026, Lilly finalized another significant agreement with Innovent Biologics, a deal worth up to $8.85 billion. The company is ...

Through this partnership, Eli Lilly secures exclusive worldwide rights to selected preclinical oral drug candidates, which reportedly include a GLP-1 receptor agonist for diabetes treatment. Insilico ...

On Wednesday PM Christopher Luxon announced that after listening to concerns about the Fisheries Amendment Bill, sections ...

Fisheries Minister Shane Jones has been forced into a major U-turn over his plans to scrap most minimum size limits for ...

High rates of complete skin clearance achieved at Week 24 and Week 52 in ICONIC-ADVANCE 1 and 2 studies.- Completely clear skin achieved at Week 52 in nearly 60% of adolescents treated with ...